School of Health Care Administration, College of Management, Taipei Medical University, Taipei, Taiwan.
Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital; Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine; and Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan.
Clin Genitourin Cancer. 2022 Apr;20(2):e126-e134. doi: 10.1016/j.clgc.2021.11.013. Epub 2021 Dec 1.
To investigate the age and gender differences among chronic dialysis patients who developed genitourinary cancers in Taiwan.
Incident hemodialysis patients aged 20 years or older were selected for retrospective cohort study from the National Health Insurance Research Database between 2002 and 2015, and the Taiwan Cancer Registry Database between 2007 and 2015. A two-step approach was employed to find the respective matched controls of non-dialysis patients. Finally, 65,450 dialysis patients and 261,800 non-dialysis patients were matched for further analysis. New diagnosis of genitourinary cancers during follow-up was the primary outcome of interest.
Dialysis was significantly associated with increased risk of all types of genitourinary cancers (P < .001), substantially within the first two years after dialysis initiation. Cox proportional hazard analysis showed a significantly increased hazard ratio (HR 6.58, 95% CI 6.05-7.16) among dialysis patients after multivariate adjustment, and the highest risk was bladder cancer (HR 7.85, 95% CI 6.97-8.84). Subgroup analysis showed younger dialysis patients (20-49 years old) had the highest risk of genitourinary cancer, especially females, in this subgroup with the highest risk of bladder cancer (HR 58.08, 95% CI 13.88-243.06).
The risks of all site-specific genitourinary cancers were increased in chronic dialysis patients, especially in younger females. Developing different screening strategies for these high-risk patients is necessary.
This study compared the effect of sex, age and dialysis duration on the susceptibility to develop genitourinary cancers in dialysis patients through the national health database linkage in Taiwan. We matched 65,450 dialysis patients and 261,800 non-dialysis patients for further analysis. Younger and female dialysis patients were at higher risk of kidney and bladder cancers.
本研究旨在探究在台湾,接受慢性透析治疗的患者发生泌尿系统癌症的年龄和性别差异。
本研究采用回顾性队列研究,从 2002 年至 2015 年的国家健康保险研究数据库和 2007 年至 2015 年的台湾癌症登记数据库中选取年龄在 20 岁及以上的接受 incident hemodialysis 治疗的患者。采用两步法为非透析患者匹配各自的对照。最终,有 65450 例透析患者和 261800 例非透析患者被匹配用于进一步分析。随访期间新诊断的泌尿系统癌症是主要观察结局。
与非透析患者相比,透析患者发生各种泌尿系统癌症的风险显著增加(P<.001),且在透析开始后的前两年内风险显著增加。多变量调整后的 Cox 比例风险分析显示,透析患者的危险比(HR)为 6.58(95%可信区间 6.05-7.16),其中膀胱癌的风险最高(HR 7.85,95%可信区间 6.97-8.84)。亚组分析显示,年轻的透析患者(20-49 岁)发生泌尿系统癌症的风险最高,尤其是女性,其中膀胱癌的风险最高(HR 58.08,95%可信区间 13.88-243.06)。
慢性透析患者发生各种部位的泌尿系统癌症的风险增加,尤其是年轻女性。对于这些高危患者,需要制定不同的筛查策略。
摘要:本研究通过台湾国家健康数据库的关联,比较了性别、年龄和透析时间对透析患者发生泌尿系统癌症易感性的影响。我们对 65450 例透析患者和 261800 例非透析患者进行了匹配分析。年轻和女性透析患者发生肾脏和膀胱癌的风险更高。